ACE2 inhibits angiotensin-II upregulation by degrading angiotensin-II into the primary products Ang-(1–7), which could counter the debilitating effects of RAS hyperactivity such as hyperglycemia, hypertension, cardiac dysfunction and fibrosis [47]. This evidence concerns the gene ACE2 and Hyperglycemia.